Angela Cenci - Related publications

Basal Ganglia Pathophysiology Unit, Experimental Medical Science, Lund University 
Parkinson's disease, L-DOPA induced dyskinesia
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2020 Calabrese V, Di Maio A, Marino G, Cardinale A, Natale G, De Rosa A, Campanelli F, Mancini M, Napolitano F, Avallone L, Calabresi P, Usiello A, Ghiglieri V, Picconi B. Rapamycin, by Inhibiting mTORC1 Signaling, Prevents the Loss of Striatal Bidirectional Synaptic Plasticity in a Rat Model of L-DOPA-Induced Dyskinesia. Frontiers in Aging Neuroscience. 12: 230. PMID 32848709 DOI: 10.3389/fnagi.2020.00230   
2020 Gul Z, Duyu G, Altinbas B, Buyukuysal RL. K channel blockage with 3,4-diaminopyridine potentiates the effect of L-DOPA on dopamine release in striatal slices prepared from 6-OHDA pre-treated rats. Experimental Brain Research. PMID 32870323 DOI: 10.1007/s00221-020-05912-w   
2020 Fonteles AA, Neves JCS, Menezes APF, Pereira JF, Silva ATA, Cunha RA, Andrade GM. ATP Signaling Controlling Dyskinesia Through P2X7 Receptors. Frontiers in Molecular Neuroscience. 13: 111. PMID 32848592 DOI: 10.3389/fnmol.2020.00111   
2020 Olanow CW, Calabresi P, Obeso JA. Continuous Dopaminergic Stimulation as a Treatment for Parkinson's Disease: Current Status and Future Opportunities. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 32816321 DOI: 10.1002/mds.28215   
2020 Cerri S, Blandini F. An update on the use of non-ergot dopamine agonists for the treatment of Parkinson's disease. Expert Opinion On Pharmacotherapy. 1-13. PMID 32804544 DOI: 10.1080/14656566.2020.1805432   
2020 Altwal F, Moon C, West AR, Steiner H. The Multimodal Serotonergic Agent Vilazodone Inhibits L-DOPA-Induced Gene Regulation in Striatal Projection Neurons and Associated Dyskinesia in an Animal Model of Parkinson's Disease. Cells. 9. PMID 33050305 DOI: 10.3390/cells9102265   
2020 Stemick J, Gauer C, Wihan J, Moceri S, Xiang W, von Hörsten S, Kohl Z, Winkler J. Compensatory neuritogenesis of serotonergic afferents within the striatum of a transgenic rat model of Parkinson's disease. Brain Research. 147119. PMID 32919983 DOI: 10.1016/j.brainres.2020.147119   
2020 Yang C, Qiu Y, Qing Y, Xu J, Dai W, Hu X, Wu X. Synergistic effect of electric stimulation and mesenchymal stem cells against Parkinson's disease. Aging. 12. PMID 32836217 DOI: 10.18632/aging.103477   
2020 Sun Y, Lu XJ, Fu X, Zhang Y, Zhan Y, Liu J, Zhao L, Xia CL. Engrafted primary type-2 astrocytes improve the recovery of the nigrostriatal pathway in a rat model of Parkinson's disease. Molecular and Cellular Biochemistry. PMID 33070275 DOI: 10.1007/s11010-020-03931-3   
2020 Chung SJ, Lee S, Yoo HS, Lee YH, Lee HS, Choi Y, Lee PH, Yun M, Sohn YH. Association of the Non-Motor Burden with Patterns of Striatal Dopamine Loss in de novo Parkinson's Disease. Journal of Parkinson's Disease. PMID 32925098 DOI: 10.3233/JPD-202127   
2020 Bayo-Olugbami A, Nafiu AB, Amin A, Ogundele OM, Lee CC, Owoyele BV. Vitamin D attenuated 6-OHDA-induced behavioural deficits, dopamine dysmetabolism, oxidative stress, and neuro-inflammation in mice. Nutritional Neuroscience. 1-12. PMID 32912107 DOI: 10.1080/1028415X.2020.1815331   
2020 Han C, Shen H, Yang Y, Sheng Y, Wang J, Li W, Zhou X, Guo L, Zhai L, Guan Q. Antrodia camphorata polysaccharide resists 6-OHDA-induced dopaminergic neuronal damage by inhibiting ROS-NLRP3 activation. Brain and Behavior. e01824. PMID 32902155 DOI: 10.1002/brb3.1824   
2020 Yu SJ, Chen S, Yang YY, Glotfelty EJ, Jung J, Kim HK, Choi HI, Choi DS, Hoffer BJ, Greig NH, Wang Y. PT320, Sustained-Release Exendin-4, Mitigates L-DOPA-Induced Dyskinesia in a Rat 6-Hydroxydopamine Model of Parkinson's Disease. Frontiers in Neuroscience. 14: 785. PMID 32848559 DOI: 10.3389/fnins.2020.00785   
2020 Blosser JA, Podolsky E, Lee D. L-DOPA-Induced Dyskinesia in a Genetic Drosophila Model of Parkinson's Disease. Experimental Neurobiology. 29: 273-284. PMID 32921640 DOI: 10.5607/en20028   
2020 Lecours C, St-Pierre MK, Picard K, Bordeleau M, Bourque M, Awogbindin IO, Benadjal A, Ibanez FG, Gagnon D, Cantin L, Parent M, Di Paolo T, Tremblay ME. Levodopa partially rescues microglial numerical, morphological, and phagolysosomal alterations in a monkey model of Parkinson's disease. Brain, Behavior, and Immunity. PMID 32755645 DOI: 10.1016/j.bbi.2020.07.044   
2020 de Campos BH, de Jager L, Reginato GS, Pereira RS, Crestani CC, Pinge-Filho P, Martins-Pinge MC. Cardiovascular evaluation of female rats with 6-OHDA-induced parkinsonism: Possible protection by ovarian hormones and participation of nitric oxide. Life Sciences. 259: 118259. PMID 32795538 DOI: 10.1016/j.lfs.2020.118259   
2020 Lin CH, Wei PC, Chen CM, Huang YT, Lin JL, Lo YS, Lin JL, Lin CY, Wu YR, Chang KH, Lee-Chen GJ. Lactulose and Melibiose Attenuate MPTP-Induced Parkinson's Disease in Mice by Inhibition of Oxidative Stress, Reduction of Neuroinflammation and Up-Regulation of Autophagy. Frontiers in Aging Neuroscience. 12: 226. PMID 32848705 DOI: 10.3389/fnagi.2020.00226   
2020 Liu Y, Jin W, Deng Z, Wang J, Zhang Q. Preparation and Neuroprotective Activity of Glucuronomannan Oligosaccharides in an MPTP-Induced Parkinson's Model. Marine Drugs. 18. PMID 32842556 DOI: 10.3390/md18090438   
2020 Biolchi AM, de Oliveira DGR, Amaral HO, Campos GAA, Gonçalves JC, de Souza ACB, Lima MR, Silva LP, Mortari MR. Fraternine, a Novel Wasp Peptide, Protects against Motor Impairments in 6-OHDA Model of Parkinsonism. Toxins. 12. PMID 32867207 DOI: 10.3390/toxins12090550   
2020 Tang J, Xu Y, Liu C, Fang Y, Cao S, Zhao C, Huang H, Zou M, Chen Z. PET imaging with [F]FP-(+)-DTBZ in 6-OHDA-induced partial and full unilaterally-lesioned model rats of Parkinson's disease and the correlations to the biological data. Nuclear Medicine and Biology. 90: 1-9. PMID 32861175 DOI: 10.1016/j.nucmedbio.2020.08.002   
2020 Parambi DGT, Saleem U, Shah MA, Anwar F, Ahmad B, Manzar A, Itzaz A, Harilal S, Uddin MS, Kim H, Mathew B. Exploring the Therapeutic Potentials of Highly Selective Oxygenated Chalcone Based MAO-B Inhibitors in a Haloperidol-Induced Murine Model of Parkinson's Disease. Neurochemical Research. PMID 32939670 DOI: 10.1007/s11064-020-03130-y   
2020 Thompson AM, Farmer K, Rowe EK, Hayley SP. Erythropoietin modulates antioxidant signalling. Molecular and Cellular Neurosciences. 103554. PMID 32971229 DOI: 10.1016/j.mcn.2020.103554   
2020 Li H, Feng Y, Chen Z, Jiang X, Zhou Z, Yuan J, Li F, Zhang Y, Huang X, Fan S, Wu X, Huang C. Pepper component 7-ethoxy-4-methylcoumarin, a novel dopamine D2 receptor agonist, ameliorates experimental Parkinson's disease in mice and Caenorhabditis elegans. Pharmacological Research. 105220. PMID 33007422 DOI: 10.1016/j.phrs.2020.105220   
2020 Manalo RVM, Medina PMB. Caffeine reduces deficits in mechanosensation and locomotion induced by L-DOPA and protects dopaminergic neurons in a transgenic model of Parkinson's disease. Pharmaceutical Biology. 58: 721-731. PMID 32715838 DOI: 10.1080/13880209.2020.1791192   
2020 Rivas-Santisteban R, Rodriguez-Perez AI, Muñoz A, Reyes-Resina I, Labandeira-García JL, Navarro G, Franco R. Angiotensin AT and AT receptor heteromer expression in the hemilesioned rat model of Parkinson's disease that increases with levodopa-induced dyskinesia. Journal of Neuroinflammation. 17: 243. PMID 32807174 DOI: 10.1186/s12974-020-01908-z   
2020 Chung SJ, Lee JJ, Lee PH, Sohn YH. Emerging Concepts of Motor Reserve in Parkinson's Disease. Journal of Movement Disorders. PMID 32854486 DOI: 10.14802/jmd.20029   
2020 Artaud F, Lee PC, Mangone G, Vidailhet M, Corvol JC, Elbaz A. Longitudinal association between dopamine agonists and weight in Parkinson's disease. Parkinsonism & Related Disorders. 80: 158-164. PMID 33011605 DOI: 10.1016/j.parkreldis.2020.09.037   
2020 Aguirre-Vidal Y, Rodríguez-Ramos C, Mendieta L, Romero-Sánchez HA, Garza-Mouriño G, Benítez-Díaz Mirón MI, Castellanos-Páez ME, Pérez-Ramos J, Godínez-Chaparro B. Synergistic antiallodynic and antihyperalgesic interaction between L-DOPA and celecoxib in parkinsonian rats is mediated by NO-cGMP-ATP-sensitive K channel. European Journal of Pharmacology. 889: 173537. PMID 32971091 DOI: 10.1016/j.ejphar.2020.173537   
2020 Kouwenhoven WM, Fortin G, Penttinen AM, Florence C, Delignat-Lavaud B, Bourque MJ, Trimbuch T, Luppi MP, Salvail-Lacoste A, Legault P, Poulin JF, Rosenmund C, Awatramani R, Trudeau LÉ. VGLUT2 EXPRESSION IN DOPAMINE NEURONS CONTRIBUTES TO POST-LESIONAL STRIATAL REINNERVATION. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 32928885 DOI: 10.1523/JNEUROSCI.0823-20.2020   
2020 Wang XW, Yuan LJ, Yang Y, Zhang M, Chen WF. IGF-1 inhibits MPTP/MPP-induced autophagy on dopaminergic neurons through the IGF-1R/PI3k-Akt-mTOR pathway and GPER. American Journal of Physiology. Endocrinology and Metabolism. PMID 32865008 DOI: 10.1152/ajpendo.00071.2020   
2020 Cankara FN, Günaydın C, Bilge SS, Özmen Ö, Kortholt A. The neuroprotective action of lenalidomide on rotenone model of Parkinson's Disease: Neurotrophic and supportive actions in the substantia nigra pars compacta. Neuroscience Letters. 738: 135308. PMID 32932183 DOI: 10.1016/j.neulet.2020.135308   
2020 Hui Y, Du C, Xu T, Zhang Q, Tan H, Liu J. Dopamine D receptors in the lateral habenula regulate depression-related behaviors via a pre-synaptic mechanism in experimental Parkinson's disease. Neurochemistry International. 104844. PMID 32891683 DOI: 10.1016/j.neuint.2020.104844   
2020 Beaudry F, Huot P. The MPTP-lesioned marmoset model of Parkinson's disease: proposed efficacy thresholds that may potentially predict successful clinical trial results. Journal of Neural Transmission (Vienna, Austria : 1996). 127: 1343-1358. PMID 32860561 DOI: 10.1007/s00702-020-02247-2   
2020 Huang X, Lewis MM, Van Scoy LJ, De Jesus S, Eslinger PJ, Arnold AC, Miller AJ, Fernandez-Mendoza J, Snyder B, Harrington W, Kong L, Wang X, Sun D, Delnomdedieu M, Duvvuri S, et al. The D1/D5 Dopamine Partial Agonist PF-06412562 in Advanced-Stage Parkinson's Disease: A Feasibility Study. Journal of Parkinson's Disease. PMID 32986682 DOI: 10.3233/JPD-202188   
2020 Xu Q, Yang S, Wu F, Lin Y, Zhong J, Tang L, Hu X, Cai J. Congrong Shujing Granule-Induced GRP78 Expression Reduced Endoplasmic Reticulum Stress and Neuronal Apoptosis in the Midbrain in a Parkinson's Disease Rat Model. Evidence-Based Complementary and Alternative Medicine : Ecam. 2020: 4796236. PMID 33062012 DOI: 10.1155/2020/4796236   
2020 Li J, Guo Y, Zhao L, Sun K, Xi G, Li ZW. Ningdong Granule Upregulates the Striatal DA Transporter and Attenuates Stereotyped Behavior of Tourette Syndrome in Rats. Evidence-Based Complementary and Alternative Medicine : Ecam. 2020: 2980705. PMID 33005197 DOI: 10.1155/2020/2980705   
2020 Brugnoli A, Pisanò CA, Morari M. Striatal and nigral muscarinic type 1 and type 4 receptors modulate levodopa-induced dyskinesia and striato-nigral pathway activation in 6-hydroxydopamine hemilesioned rats. Neurobiology of Disease. 144: 105044. PMID 32798726 DOI: 10.1016/j.nbd.2020.105044   
2020 Saini N, Akhtar A, Chauhan M, Dhingra N, Pilkhwal Sah S. Protective effect of Indole-3-carbinol, an NF-κB inhibitor in experimental paradigm of Parkinson's disease: In silico and in vivo studies. Brain, Behavior, and Immunity. PMID 32800927 DOI: 10.1016/j.bbi.2020.08.001   
2020 Zhu J, Sun T, Zhang J, Liu Y, Wang D, Zhu H, Yao H, Ding J, Hu G, Lu M. Drd2 biased agonist prevents neurodegeneration against NLRP3 inflammasome in Parkinson's disease model via a β-arrestin2-biased mechanism. Brain, Behavior, and Immunity. PMID 32861720 DOI: 10.1016/j.bbi.2020.08.025   
2020 Gao MR, Wang M, Jia YY, Tian DD, Liu A, Wang WJ, Yang L, Chen JY, Yang Q, Liu R, Wu YM. Echinacoside protects dopaminergic neurons by inhibiting NLRP3/Caspase-1/IL-1β signaling pathway in MPTP-induced Parkinson's disease model. Brain Research Bulletin. 164: 55-64. PMID 32846198 DOI: 10.1016/j.brainresbull.2020.08.015   
2020 Butkovich LM, Houser MC, Chalermpalanupap T, Porter-Stransky KA, Iannitelli AF, Boles JS, Lloyd GM, Coomes AS, Eidson LN, De Sousa Rodrigues ME, Oliver DL, Kelly SD, Chang J, Bengoa-Vergniory N, Wade-Martins R, et al. Transgenic mice expressing human alpha-synuclein in noradrenergic neurons develop locus coeruleus pathology and non-motor features of Parkinson's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 32868457 DOI: 10.1523/JNEUROSCI.1468-19.2020   
2020 Ribeiro MJ, Vercouillie J, Arlicot N, Tauber C, Gissot V, Mondon K, Barantin L, Cottier JP, Maia S, Deloye JB, Emond P, Guilloteau D. Usefulness of PET With [F]LBT-999 for the Evaluation of Presynaptic Dopaminergic Neuronal Loss in a Clinical Environment. Frontiers in Neurology. 11: 754. PMID 32973645 DOI: 10.3389/fneur.2020.00754   
2020 Zhu YH, Huan F, Wang J, Xie X, Yu G, Wang X, Jiang L, Gao R, Xiao H, Ding H, Wang J. MPTP induced Parkinson's disease in mouse: potential association between neurotransmitter disturbance and gut microbiota dysbiosis. Acs Chemical Neuroscience. PMID 32926778 DOI: 10.1021/acschemneuro.0c00475   
2020 Shimizu J, Kasai T, Yoshida H, Huynh AM, Nakao-Azuma Y, Shinomoto M, Tokuda T, Mizuno T, Yamaguchi M. Novel Drosophila model for parkinsonism by targeting phosphoglycerate kinase. Neurochemistry International. 139: 104816. PMID 32758590 DOI: 10.1016/j.neuint.2020.104816   
2020 El-Sherbeni AA, Stocco MR, Wadji FB, Tyndale RF. Addressing the instability issue of dopamine during microdialysis: the determination of dopamine, serotonin, methamphetamine and its metabolites in rat brain. Journal of Chromatography. A. 1627: 461403. PMID 32823108 DOI: 10.1016/j.chroma.2020.461403   
2020 Fujita M, Ochiai Y, Takeda TC, Hagino Y, Kobayashi K, Ikeda K. Increase in excitability of hippocampal neurons during novelty-induced hyperlocomotion in dopamine-deficient mice. Molecular Brain. 13: 126. PMID 32948232 DOI: 10.1186/s13041-020-00664-8   
2020 Siddu A, David LS, Lauinger N, Chen CX, St-Pierre M, Alpaugh M, Durcan T, Cicchetti F. Beneficial effects of cysteamine in Thy1-α-Syn mice and induced pluripotent stem cells with a SNCA gene triplication. Neurobiology of Disease. 105042. PMID 32798729 DOI: 10.1016/j.nbd.2020.105042   
2020 Mubashir N, Fatima R, Naeem S. Identification of Novel Phyto-chemicals from Ocimum basilicum for the Treatment of Parkinson's Disease using In Silico Approach. Current Computer-Aided Drug Design. 16: 420-434. PMID 32883197 DOI: 10.2174/1573409915666190503113617   
2020 Kerstens VS, Fazio P, Sundgren M, Matheson GJ, Franzén E, Halldin C, Cervenka S, Svenningsson P, Varrone A. Reliability of dopamine transporter PET measurements with [F]FE-PE2I in patients with Parkinson's disease. Ejnmmi Research. 10: 95. PMID 32797307 DOI: 10.1186/s13550-020-00676-4   
2020 Subbarayan MS, Hudson C, Moss LD, Nash KR, Bickford PC. T cell infiltration and upregulation of MHCII in microglia leads to accelerated neuronal loss in an α-synuclein rat model of Parkinson's disease. Journal of Neuroinflammation. 17: 242. PMID 32799878 DOI: 10.1186/s12974-020-01911-4